Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Natalya Hakim"'
Autor:
Ethan Strattan, Senthilnathan Palaniyandi, Reena Kumari, Jing Du, Natalya Hakim, Timothy Huang, Melissa V. Kesler, C. Darrell Jennings, Jamie L. Sturgill, Gerhard C. Hildebrandt
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Allogeneic hematopoietic stem cell transplant (allo-HSCT) is often used to treat acute leukemia or defects of hematopoiesis. Its widespread use is hampered by graft-vs.-host disease (GVHD), which has high morbidity and mortality in both acute and chr
Externí odkaz:
https://doaj.org/article/a4a925a985e64d83a1dbfdad6c855820
Publikováno v:
Annals of Hematology. 101:1879-1881
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae1f118ae89ef5d34a3b546ab48a9de2
https://doi.org/10.1007/s00277-022-04834-7
https://doi.org/10.1007/s00277-022-04834-7
Autor:
Gerhard C. Hildebrandt, Ethan Strattan, Natalya Hakim, Senthilnathan Palaniyandi, Melissa Kesler, Reinhold Munker, Reena Kumari, Sabarinath Venniyil Radhakrishnan
Publikováno v:
Transplantation
BACKGROUND. Prolyl hydroxylase inhibitors (PHI) promote stabilization of hypoxia-inducible factor-1 alpha and affect signaling cascades of inflammation and cell death. Their beneficial use in experimental models of ulcerative colitis and lung allogra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86ca880893bde2c0950c65a80adc411f
https://doi.org/10.1097/tp.0000000000003383
https://doi.org/10.1097/tp.0000000000003383
Autor:
Senthilnathan Palaniyandi, Ethan Strattan, Reena Kumari, Natalya Hakim, Melissa Kesler, Mutiah Apatira, Fabiola Bittencourt, Longcheng Wang, Zhaozhong Jia, Tarikere Gururaja, Ronald Hill, Gerhard C. Hildebrandt
Publikováno v:
Transplantation and Cellular Therapy. 28:S279-S280
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f637d782a769eae6bda6d8916a0d1d0
https://doi.org/10.1016/s2666-6367(22)00521-8
https://doi.org/10.1016/s2666-6367(22)00521-8
Autor:
Gerhard C. Hildebrandt, Ethan Strattan, Jamie Sturgill, Natalya Hakim, Reena Kumari, Timothy Huang, Melissa Kesler, Jing Du, C. Darrell Jennings, Senthilnathan Palaniyandi
Allogeneic hematopoietic stem cell transplant (allo-HSCT) is often used to treat acute leukemia or defects of hematopoiesis. Its widespread use is hampered by graft-versus-host disease (GVHD), which has high morbidity and mortality in both acute and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76036e46bb05840555b9e8a09812eaa4
https://doi.org/10.1101/668236
https://doi.org/10.1101/668236
Autor:
Gerhard C. Hildebrandt, Jing Du, Senthilnathan Palaniyandi, Reena Kumari, Ethan Strattan, Katharina Kohler, Natalya Hakim, Melissa Kesler
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S300-S301
Introduction Graft versus host disease (GVHD) leads to significant post-transplant morbidity and mortality after allogeneic hematopoietic cell transplant (allo-HCT). Vedolizumab (VDZ) is a monoclonal antibody targeting the homing of T cells to the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::253c48611d4866ecd5823417aa89c5ef
https://doi.org/10.1016/j.bbmt.2018.12.681
https://doi.org/10.1016/j.bbmt.2018.12.681
Publikováno v:
American Journal of Clinical Pathology. 152:S62-S62
Introduction Perivascular epithelioid cell tumors (PEComas) are defined by the World Health Organization (WHO) as mesenchymal tumors arising from perivascular epithelioid cells with myomelanocytic immunophenotype. In the kidney, they are often referr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d579c26907cc5a08666713db237877
https://doi.org/10.1093/ajcp/aqz113.061
https://doi.org/10.1093/ajcp/aqz113.061